<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:p="urn:schemas-microsoft-com:office:powerpoint"
xmlns:oa="urn:schemas-microsoft-com:office:activation"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=PowerPoint.Slide>
<meta name=Generator content="Microsoft PowerPoint 10">
<link id=Main-File rel=Main-File href="../2004-4068S1_01_Colman.htm">
<link rel=Preview href=preview.wmf>
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
p\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
v\:textbox {display:none;}
</style>
<![endif]-->
<title>Advisory Committee Mtgs. Sample PPT</title>
<meta name=Description content="9/9/2004: The Amphetamines">
<link rel=Stylesheet href="master03_stylesheet.css">
<![if !ppt]>
<style media=print>
<!--.sld
	{left:0px !important;
	width:6.0in !important;
	height:4.5in !important;
	font-size:107% !important;}
-->
</style>
<script src=script.js></script><script><!--
if( !IsNts() ) Redirect( "PPTSld" );
//--></script><!--[if vml]><script>g_vml = 1;
</script><![endif]--><![endif]><p:slidetransition advancetime="0" flag="1"/><o:shapelayout
 v:ext="edit">
 <o:idmap v:ext="edit" data="24"/>
</o:shapelayout>
</head>

<body lang=EN-US style='margin:0px;background-color:black'
onclick="DocumentOnClick()" onresize="_RSW()" onload="LoadSld()"
onkeypress="_KPH()">

<div id=SlideObj class=sld style='position:absolute;top:0px;left:0px;
width:534px;height:400px;font-size:16px;background-color:#01016E;clip:rect(0%, 101%, 101%, 0%);
visibility:hidden'><p:slide coordsize="720,540"
 colors="#FFFFFF,#000000,#808080,#000000,#00CC99,#3333CC,#CCCCFF,#B2B2B2"
 masterhref="master03.xml">
 <p:shaperange href="master03.xml#_x0000_s1025"/><![if !vml]><img
 src="master03_background.gif" v:shapes="_x0000_s1025" style='position:absolute;
 top:0%;left:0%;width:100.0%;height:100.0%'><![endif]><![if !ppt]><p:shaperange
  href="master03.xml#_x0000_s1031"/><p:shaperange
  href="master03.xml#_x0000_s1030"/>
 <div v:shape="_x0000_s1030" class=O>
 <div style='text-align:right;position:absolute;top:91.25%;left:72.65%;
 width:18.91%;height:3.0%'><span style='font-size:58%;color:#E5BD75'><span
 style='mso-spacerun:yes'> </span></span><span style='font-family:Arial;
 font-size:50%;color:#E5BD75;mso-field-code:meta16'><b>3</b></span><span
 style='font-family:Arial;font-size:50%;color:#E5BD75;mso-special-format:lastCR;
 display:none'><b>&#13;</b></span></div>
 </div>
 <p:shaperange href="master03.xml#_x0000_s1036"/><![if !vml]><img border=0
 v:shapes="_x0000_s1036" src="master03_image002.gif" style='position:absolute;
 top:90.0%;left:7.49%;width:7.49%;height:4.0%'><![endif]><p:shaperange
  href="master03.xml#_x0000_s1038"/><![if !vml]><img border=0
 v:shapes="_x0000_s1042" src="master03_image003.gif" style='position:absolute;
 top:0%;left:0%;width:2.62%;height:100.5%'><![endif]>
 <div v:shape="_x0000_s1038" class=O>
 <div style='mso-line-spacing:"80 0 0";position:absolute;top:90.0%;left:15.73%;
 width:55.61%;height:2.75%'><span style='font-family:Arial;font-size:50%;
 text-shadow:auto;color:#E5BD75'><b>Endocrinologic and Metabolic Drugs
 Advisory<span style='mso-spacerun:yes'>  </span>Committee<span
 style='mso-spacerun:yes'>  </span>&#13;</b></span></div>
 <div style='mso-line-spacing:"80 0 0";position:absolute;top:92.25%;left:15.73%;
 width:48.12%;height:2.75%'><span style='font-family:Arial;font-size:50%;
 text-shadow:auto;color:#E5BD75'><b>September 8, 2004</b></span><span
 style='font-family:Arial;font-size:50%;color:#E5BD75;mso-special-format:lastCR;
 display:none'><b>&#13;</b></span></div>
 </div>
 <p:shaperange href="master03.xml#Base"/><![if !ppt]>
 <div style='visibility:hidden'><![endif]><![if !ppt]></div>
 <![endif]><![endif]><p:shaperange href="master03.xml#_x0000_m1026"/><v:shape
  id="_x0000_s24578" type="#_x0000_m1026" style='position:absolute;left:54pt;
  top:0;width:612pt;height:90pt'>
  <v:fill o:detectmouseclick="f"/>
  <v:stroke o:forcedash="f"/>
  <o:lock v:ext="edit" text="f"/>
  <p:placeholder type="title"/></v:shape><![if !ppt]>
 <div style='position:absolute;top:0%;left:7.49%;width:85.39%;height:17.0%;
 filter:DropShadow(Color=#000000, OffX=3, OffY=1)'><![endif]>
 <div v:shape="_x0000_s24578" class=T style='position:absolute;top:26.47%;
 left:1.09%;width:97.36%;height:50.0%'>The Amphetamines</div>
 <![if !ppt]></div>
 <![endif]><p:shaperange href="master03.xml#_x0000_m1027"/><v:shape id="_x0000_s24579"
  type="#_x0000_m1027" style='position:absolute;left:54pt;top:108pt;width:612pt;
  height:324pt'>
  <v:fill o:detectmouseclick="f"/>
  <v:stroke o:forcedash="f"/>
  <o:lock v:ext="edit" text="f"/>
  <p:placeholder type="body" position="1"/></v:shape><![if !ppt]>
 <div style='position:absolute;top:20.0%;left:7.49%;width:97.56%;height:101.5%;
 filter:DropShadow(Color=#000000, OffX=2, OffY=1)'><![endif]>
 <div v:shape="_x0000_s24579">
 <div class=B style='mso-line-spacing:"80 5 0"'><span style='position:absolute;
 top:.24%;left:4.79%;width:93.66%;height:4.43%'><span style='font-size:63%;
 font-weight:normal'><span style='mso-special-format:bullet;color:#F9D26F;
 position:absolute;left:-4.09%'>•</span></span><span style='font-size:63%'>Lesses,
 M.F. and Myerson A. Benzedrine sulfate as an aid </span></span><span
 style='position:absolute;top:3.69%;left:4.79%;width:95.0%;height:4.43%'><span
 style='font-size:63%'>in the treatment of obesity. 1938 </span><span
 style='font-size:63%'><b><i>New Engl J Med; </i></b></span><span
 style='font-size:63%'>218:119-</span></span><span style='position:absolute;
 top:7.14%;left:4.79%;width:81.38%;height:4.43%'><span style='font-size:63%'>124&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0"'><span style='position:absolute;
 top:11.08%;left:4.79%;width:95.0%;height:4.43%'><span style='font-size:63%;
 font-weight:normal'><span style='mso-special-format:bullet;color:#F9D26F;
 position:absolute;left:-4.04%'>•</span></span><span style='font-size:63%'>Benzedrine
 (amphetamine sulfate) approved by the FDA in </span></span><span
 style='position:absolute;top:14.53%;left:4.79%;width:81.38%;height:4.43%'><span
 style='font-size:63%'>1939&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:18.22%;
 left:.95%;width:85.22%;height:4.43%'><span style='position:absolute;
 top:0%;left:4.5%;width:95.49%;height:100.0%'><span style='font-size:63%;
 font-weight:normal'><span style='mso-special-format:bullet;color:#F9D26F;
 position:absolute;left:-4.71%'>•</span></span><span style='font-size:63%'>Desoxyephedrine
 approved in 1943 &#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:21.92%;
 left:.95%;width:96.92%;height:4.43%'><span style='position:absolute;
 top:0%;left:3.96%;width:96.03%;height:100.0%'><span style='font-size:63%;
 font-weight:normal'><span style='mso-special-format:bullet;color:#F9D26F;
 position:absolute;left:-4.12%'>•</span></span><span style='font-size:63%'>Obesity
 indication for desoxyephedrine approved in 1947&#13;</span></span></div>
 <div class=B1 style='mso-line-spacing:"80 5 0"'><span style='position:absolute;
 top:25.61%;left:9.4%;width:82.91%;height:4.43%'><span style='font-size:63%;
 font-weight:normal'><span style='mso-special-format:bullet;color:#F9D26F;
 position:absolute;left:-3.93%'>–</span></span><span style='font-size:63%'>“The
 sympathomimetic amines have been found of </span></span><span
 style='position:absolute;top:29.31%;left:9.4%;width:85.41%;height:4.43%'><span
 style='font-size:63%'>value, when administered under the supervision of a </span></span><span
 style='position:absolute;top:32.75%;left:9.4%;width:88.29%;height:4.43%'><span
 style='font-size:63%'>physician, as an adjunct to the dietary management of </span></span><span
 style='position:absolute;top:36.2%;left:9.4%;width:76.96%;height:4.43%'><span
 style='font-size:63%'>obesity”&#13;</span></span></div>
 <div class=B1 style='mso-line-spacing:"80 5 0"'><span style='position:absolute;
 top:39.9%;left:9.4%;width:87.9%;height:4.43%'><span style='font-size:63%;
 font-weight:normal'><span style='mso-special-format:bullet;color:#F9D26F;
 position:absolute;left:-3.71%'>–</span></span><span style='font-size:63%'>warned
 against its use in persons with cardiovascular </span></span><span
 style='position:absolute;top:43.59%;left:9.4%;width:86.18%;height:4.43%'><span
 style='font-size:63%'>disease, hypertension, or insomnia and in those who </span></span><span
 style='position:absolute;top:47.04%;left:9.4%;width:76.96%;height:4.43%'><span
 style='font-size:63%'>were “neurotic or hyperexcitable.” &#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0"'><span style='position:absolute;
 top:50.73%;left:4.79%;width:90.78%;height:4.43%'><span style='font-size:63%;
 font-weight:normal'><span style='mso-special-format:bullet;color:#F9D26F;
 position:absolute;left:-4.22%'>•</span></span><span style='font-size:63%'>Amphetamines:
 amphetamine sulfate, desoxyephedrine </span></span><span style='position:absolute;
 top:54.18%;left:4.79%;width:93.85%;height:4.43%'><span style='font-size:63%'>(methamphetamine),
 dextroamphetamine, amphetamine + </span></span><span style='position:absolute;
 top:57.88%;left:4.79%;width:81.38%;height:4.43%'><span style='font-size:63%'>barbiturate&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:61.57%;
 left:.95%;width:85.22%;height:4.43%'><span style='position:absolute;
 top:0%;left:4.5%;width:95.49%;height:100.0%'><span style='font-size:63%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.71%'>•</span></span><span
 style='font-size:63%;display:none'>&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:65.27%;
 left:.95%;width:85.22%;height:4.43%'><span style='mso-special-format:nobullet;
 display:none;color:#F9D26F'>•</span><span style='font-size:63%;display:none'>&#13;</span></div>
 <div class=B1 style='mso-line-spacing:"80 5 0";position:absolute;top:68.96%;
 left:6.14%;width:80.03%;height:4.43%'><span style='position:absolute;
 top:0%;left:4.07%;width:96.16%;height:100.0%'><span style='font-size:63%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.23%'>–</span></span><span
 style='font-size:63%;display:none'>&#13;</span></span></div>
 <div class=B1 style='mso-line-spacing:"80 5 0";position:absolute;top:72.66%;
 left:6.14%;width:80.03%;height:3.94%'><span style='position:absolute;
 top:0%;left:4.07%;width:96.16%;height:100.0%'><span style='font-size:56%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.23%'>–</span></span><span
 style='font-size:56%;display:none'>&#13;</span></span></div>
 <div class=B1 style='mso-line-spacing:"80 5 0";position:absolute;top:76.1%;
 left:6.14%;width:80.03%;height:3.94%'><span style='position:absolute;
 top:0%;left:4.07%;width:96.16%;height:100.0%'><span style='font-size:56%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.23%'>–</span></span><span
 style='font-size:56%;display:none'>&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:79.55%;
 left:.95%;width:85.22%;height:3.94%'><span style='position:absolute;
 top:0%;left:4.5%;width:95.49%;height:100.0%'><span style='font-size:56%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.71%'>•</span></span><span
 style='font-size:56%;display:none'>&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:82.75%;
 left:.95%;width:85.22%;height:3.94%'><span style='mso-special-format:nobullet;
 display:none;color:#F9D26F'>•</span><span style='font-size:56%;display:none'>&#13;</span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:86.2%;
 left:.95%;width:85.22%;height:3.94%'><span style='position:absolute;
 top:0%;left:4.5%;width:95.49%;height:100.0%'><span style='font-size:56%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.71%'>•</span></span><span
 style='font-size:56%;display:none'>&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:89.4%;
 left:.95%;width:85.22%;height:3.94%'><span style='position:absolute;
 top:0%;left:4.5%;width:95.49%;height:100.0%'><span style='font-size:56%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.71%'>•</span></span><span
 style='font-size:56%;display:none'>&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:92.85%;
 left:.95%;width:85.22%;height:3.94%'><span style='position:absolute;
 top:0%;left:4.5%;width:95.49%;height:100.0%'><span style='font-size:56%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.71%'>•</span></span><span
 style='font-size:56%;display:none'>&#13;</span></span></div>
 <div class=B style='mso-line-spacing:"80 5 0";position:absolute;top:96.3%;
 left:.95%;width:85.22%;height:3.94%'><span style='position:absolute;
 top:0%;left:4.5%;width:95.49%;height:100.0%'><span style='font-size:56%;
 font-weight:normal;visibility:hidden'><span style='mso-special-format:bullet;
 color:#F9D26F;position:absolute;left:-4.71%'>•</span></span><span
 style='font-size:56%;mso-special-format:lastCR;display:none'>&#13;</span></span></div>
 </div>
 <![if !ppt]></div>
 <![endif]></p:slide></div>

</body>

</html>
